Intellectual Property

Two major aspects of Intellectual Property must be considered for formulations; the drafting of patents, and avoidance of patent infringement during the formulation and development of generic versions of a medicinal product.

Many generic companies lose their cases, not because they necessarily deliberately infringe a patent, but because they do not understand the difference between science and case law, and that case law will prevail regardless of the science.

For the innovator companies, properly qualified expert witnesses are equally important. Very often the litigation focuses on what a person of ordinary skill in the arts would/could have known at the time of the patent was filed.

FinnBrit Consulting has the necessary experience to advise pharmaceutical companies formulation patents from drafting it to acting as an Expert Witness.

Find us on FaceBook


All information published throughout is intended for information only, and does not contain any warranties, implied or otherwise.

Copyright © 2007 FinnBrit Consulting and Lenk Design. All rights reserved.

Site Map